Delivery Order SPE2DE24D0013-SPE2D626F80K0
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $5,775.00 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The delivery order, designated XPRS-COV2-10, is expected to be completed by November 20, 2025, and carries no set-aside designation. This award represents a task order issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $6,078.92 by the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with a completion date of December 26, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, carries no set-aside designation and represents procurement of diagnostic reagents and test kits for the GeneXpert diagnostic platform. The order is placed under Cepheid's existing Indefinite Delivery Contract with...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $8,160 delivery order (4570311575 | XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, falls under a larger single-award Indefinite Delivery Contract valued at $6.7 million with the Department of Veterans...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $1,925 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on October 21, 2025, with an ultimate completion date of October 28, 2025. The contract, designated XPRS-COV2-10, represents a delivery order for diagnostic reagents and test kits—specifically XPRS-COV2-10 cartridges for respiratory pathogen detection on the GeneXpert diagnostic platform....
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $10,200.00 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025. The firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, is designated as XPRS4PLEX-10 and carries no set-aside designation. This delivery order falls under Cepheid's broader contracting relationship with federal healthcare agencies, where...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $3,400 under contract XPRS4PLEX-10 by the Defense Logistics Agency's Medical Supply Chain on December 3, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a procurement of diagnostic testing supplies from Cepheid, a leading manufacturer of molecular diagnostic systems and reagents specializing in...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,720 by the Defense Logistics Agency Medical Supply Chain on December 17, 2025, with an ultimate completion date of December 24, 2025. This delivery order, designated XPRS4PLEX-10, is issued under an Indefinite Delivery Contract framework and carries no set-aside designation. The contract calls for the delivery of diagnostic reagents and test kits designed for Cepheid's GeneXpert...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F80K0Delivery Order
Cepheid Inc. was awarded a firm fixed-price delivery order valued at $16,320 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 13, 2026. The delivery order, designated 4570410037 XPRS4PLEX-10, represents work performed at Cepheid's headquarters in Sunnyvale, California, and carries no set-aside designation. This award falls under Cepheid's existing Indefinite Delivery Contract framework with the Department of Veterans Affairs' Veterans Integrated Service Network 17, valued at $6.74 million through December 28, 2029, which establishes the terms for procurement of molecular diagnostic reagents and test kits for the GeneXpert diagnostic platform. The specific delivery order involves XPRS4PLEX-10 cartridges, multiplex diagnostic reagents designed for rapid molecular detection of respiratory pathogens. Cepheid, a leading federal supplier of advanced molecular diagnostic systems, has established itself as a primary vendor across multiple federal healthcare agencies including the VA, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's core competency in providing GeneXpert diagnostic platform solutions and associated testing capabilities for infectious diseases including COVID-19, influenza, and respiratory syncytial virus supports critical diagnostic operations across the federal healthcare system. This delivery order continues Cepheid's role as a core supplier of molecular diagnostic testing solutions to support federal clinical laboratory operations and infectious disease detection requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 1/5/26 |